62 related articles for article (PubMed ID: 8301599)
1. The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation.
Grover GJ; Sleph PG
J Pharmacol Exp Ther; 1994 Jan; 268(1):90-6. PubMed ID: 8301599
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim.
Gross GJ; Mei DA; Sleph PG; Grover GJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):533-40. PubMed ID: 9023261
[TBL] [Abstract][Full Text] [Related]
3. Lack of a pharmacologic interaction between ATP-sensitive potassium channels and adenosine A1 receptors in ischemic rat hearts.
Grover GJ; Baird AJ; Sleph PG
Cardiovasc Res; 1996 Apr; 31(4):511-7. PubMed ID: 8689642
[TBL] [Abstract][Full Text] [Related]
4. Pertussis toxin blocks adenosine A1 receptor mediated protection of the ischemic rat heart.
Lasley RD; Mentzer RM
J Mol Cell Cardiol; 1993 Jul; 25(7):815-21. PubMed ID: 8230243
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside transport inhibition mediates lidoflazine-induced cardioprotection during intermittent aortic crossclamping.
Chang-Chun C; Masuda M; Szabò Z; Szerafin T; Szècsi J; Van Belle H; Flameng W
J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1602-9. PubMed ID: 1453724
[TBL] [Abstract][Full Text] [Related]
6. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
Ford WR; Lopaschuk GD; Schulz R; Clanachan AS
Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
[TBL] [Abstract][Full Text] [Related]
7. The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004.
Sargent CA; Grover GJ; Antonaccio MJ; McCullough JR
J Pharmacol Exp Ther; 1993 Sep; 266(3):1422-9. PubMed ID: 8371147
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
9. Transient ischemia in the presence of an adenosine deaminase plus a nucleoside transport inhibitor confers protection against contractile depression produced by hydrogen peroxide. Possible role of glycogen.
Gan XT; Cook MA; Moffat MP; Karmazyn M
J Mol Cell Cardiol; 1996 May; 28(5):1165-76. PubMed ID: 8762052
[TBL] [Abstract][Full Text] [Related]
10. A novel irreversible antagonist of the A1-adenosine receptor.
Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
[TBL] [Abstract][Full Text] [Related]
11. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.
Grover GJ; Dzwonczyk S; Sleph PG; Sargent CA
J Pharmacol Exp Ther; 1993 May; 265(2):559-64. PubMed ID: 8496806
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of adenosine in the reversibly injured heart.
Lasley RD; Mentzer RM
Ann Thorac Surg; 1995 Sep; 60(3):843-6. PubMed ID: 7677544
[TBL] [Abstract][Full Text] [Related]
13. [Effect of A1 adenosine receptor blockade on postischemic damage to the coronary microcirculation].
Di Napoli P; Di Crecchio A; Taccardi AA; Di Muzio M; Statile D; Maggi A; Giuliani P; Di Iorio P; Barsotti A
Cardiologia; 1998 Apr; 43(4):387-93. PubMed ID: 9659796
[TBL] [Abstract][Full Text] [Related]
14. Phentolamine prevents the adverse effects of adenosine on glycolysis and mechanical function in isolated working rat hearts subjected to antecedent ischemia.
Finegan BA; Gandhi M; Clanachan AS
J Mol Cell Cardiol; 2000 Jun; 32(6):1075-86. PubMed ID: 10888259
[TBL] [Abstract][Full Text] [Related]
15. Exogenous adenosine, supplied transiently during reperfusion, ameliorates depressed endogenous adenosine production in the post-ischemic rat heart.
Smolenski RT; Simmonds HA; Chambers DJ
J Mol Cell Cardiol; 1997 Jan; 29(1):333-46. PubMed ID: 9040048
[TBL] [Abstract][Full Text] [Related]
16. Modulation of epileptiform activity by adenosine A1 receptor-mediated mechanisms in the juvenile rat hippocampus.
Tancredi V; D'Antuono M; Nehlig A; Avoli M
J Pharmacol Exp Ther; 1998 Sep; 286(3):1412-9. PubMed ID: 9732405
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
[TBL] [Abstract][Full Text] [Related]
18. Predominant role of A1 adenosine receptors in mediating adenosine induced vasodilatation of rat diaphragmatic arterioles: involvement of nitric oxide and the ATP-dependent K+ channels.
Danialou G; Vicaut E; Sambe A; Aubier M; Boczkowski J
Br J Pharmacol; 1997 Aug; 121(7):1355-63. PubMed ID: 9257914
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen peroxide-induced stimulation of L-type calcium current in guinea pig ventricular myocytes and its inhibition by adenosine A1 receptor activation.
Thomas GP; Sims SM; Cook MA; Karmazyn M
J Pharmacol Exp Ther; 1998 Sep; 286(3):1208-14. PubMed ID: 9732380
[TBL] [Abstract][Full Text] [Related]
20. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
Nörenberg W; Wirkner K; Illes P
Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]